She specializes in lymphoma and Bone Marrow Transplant with a special focus in rare lymphomas like T Cell lymphoma (TCL) and Post-transplant Lymphoproliferative Disorders (PTLD). She spearheaded the translational research program in TCL at Cleveland Clinic in collaboration with researchers from the Translational Hematology Oncology Research (THOR) department. Her research priority is to gain more insight into the molecular biology of rare lymphomas and to develop novel targeted therapies to improve outcomes. She currently is the national Principal Investigator (PI) for multiple Investigator initiated trials (IIT) and the site PI for more than 10 multicenter clinical trials.